Literature DB >> 6959

Acute renal effects of new beta-adrenergic receptor site blocking agents on renal function.

P Zech, N Pozet, M Labeeuw, J Sassard, J Bernheim, M Pellet, J Traeger.   

Abstract

The effects of two new beta blockers on renal function have been studied. There were significant decreases in urine flow, urea clearance, sodium and chloride excretion rates after acute administration. Fractional excretion of sodium (FeNa) fell significantly but did not continue to fall during chronic administration. Blood pressure and plasma renin activity decreased significantly after two months' therapy. These findings suggest that beta blockers in patients with unstable cardiovascular function increase the need for concomitant diuretic therapy.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 6959

Source DB:  PubMed          Journal:  Proc Eur Dial Transplant Assoc        ISSN: 0071-2736


  6 in total

Review 1.  Systemic and regional haemodynamic profile of diuretics and alpha- and beta-blockers. A review comparing acute and chronic effects.

Authors:  A Mimran; G Ducailar
Journal:  Drugs       Date:  1988       Impact factor: 9.546

2.  Acute changes in renal function induced by bisoprolol, a new cardioselective beta-blocking agent.

Authors:  Z Glück; F C Reubi
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  beta-Adrenoceptor-blocking agents and the kidney: effect of nadolol and propranolol on the renal circulation.

Authors:  N K Hollenberg; D F Adams; D N McKinstry; G H Williams; L J Borucki; J M Sullivan
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

Review 4.  Renal effects of antihypertensive drugs.

Authors:  W A Schlueter; D C Batlle
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

5.  Acute effects of combined vasodilation and beta-adrenoceptor blockade with prizidilol on renal function.

Authors:  K Boehringer; P Weidmann; L Link; M G Bianchetti; H Schiffl; F C Reubi
Journal:  Br J Clin Pharmacol       Date:  1983-02       Impact factor: 4.335

6.  Cardiac and renovascular effects in the anaesthetized dog of BW A575C: a novel angiotensin converting enzyme inhibitor with beta-adrenoceptor blocking properties.

Authors:  D Cambridge; M V Whiting; G Allan
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.